KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Repligen (RGEN) Operating Expenses (2016 - 2025)

Repligen (RGEN) has disclosed Operating Expenses for 16 consecutive years, with $180.0 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 11.76% to $180.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $683.1 million through Dec 2025, up 2.02% year-over-year, with the annual reading at $683.1 million for FY2025, 2.02% up from the prior year.
  • Operating Expenses for Q4 2025 was $180.0 million at Repligen, up from $172.0 million in the prior quarter.
  • The five-year high for Operating Expenses was $204.0 million in Q4 2024, with the low at $106.5 million in Q1 2021.
  • Average Operating Expenses over 5 years is $150.9 million, with a median of $149.3 million recorded in 2021.
  • The sharpest move saw Operating Expenses soared 81.98% in 2021, then decreased 11.76% in 2025.
  • Over 5 years, Operating Expenses stood at $149.1 million in 2021, then dropped by 7.49% to $137.9 million in 2022, then increased by 13.65% to $156.7 million in 2023, then skyrocketed by 30.18% to $204.0 million in 2024, then fell by 11.76% to $180.0 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $180.0 million, $172.0 million, and $168.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.